Zenith Carex International Ltd Sues Chemonics International, Inc. for Defamation

Zenith Carex International
Limited, a leading logisticsand cou-
rier services company based in Nigeria,
has filed a defamation lawsuit against
ChemonicsInternational, Inc., a glo-
bal development firm headquartered
in Washington, D.C. The lawsuit
seeks damages in excess of $15,000,
000 and a retraction of defamatory
statements made byChemonics.
The complaint, filed in the United Sta-
tes District Court for the District of
Columbia, alleges thatChemonics pub-
lished false and defamatory statements
about Zenith Carex, accusing the com-
panyof fraud and inflated invoicing.
These statements were disseminated
through a press release issued by the US.
Department of Justice (DoJ) and
further amplified by online public-
ations, causingsignificant reputational
and financial harm to Zenith Carex.
Zenith Carex asserts that the defam-
atory statements were made with mal-
ice and reckless disregardfor the truth.
The company has consistently provided
exemplary logistics services for intern-
ationalaid programs, including those
funded by the United States Agency
for International Development
(USAID) and the Global Fund. Des-
pite a comprehensive investigation
by the Economic andFinancial Cri-
mes Commission (EFCC) in Nigeria,
which found no evidence of fraud,
and anarbitration which Chemonics
settled for lack of evidence, Chemonics
continued to propagate falseallegations
against Zenith Carex.
“We are deeply disappointed by the
actions of Chemonics and the subse-
quent damage to ourreputation,” said
a spokesperson for Zenith Carex.
“our company has always operated
with thehighest standards of integrity
and professionalism. We are committed to seeking justice and restoring our good name. ”
The lawsuit seeks compensatory and
punitive damages, as well as a public
retraction and apology from
Chemonics. Zenith Carex remains
dedicated to its mission of providing reli-
able and efficient logistics services to
support humanitarian aid efforts across
Nigeria and beyond.
